Benzinga | Aug 10, 2020 04:08PM EDT

ChemoCentryx Q2 EPS $0.29 Up From $(0.26) YoY, Sales $49.44M Up From $7.17M YoY

ChemoCentryx (NASDAQ:CCXI) reported quarterly earnings of $0.29 per share. This is a 211.54 percent increase over losses of $(0.26) per share from the same period last year. The company reported $49.44 million in sales this quarter. This is a 589.25 percent increase over sales of $7.17 million the same period last year.